Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Dec 6 2017

Antiarrhythmics

Overview

Class I - Na+ Channel Blockers
  • General principles
    • slow or block Na+ conduction preferentially in depolarized cells
      • selective for abnormal cardiac tissue that is frequently depolarized
      • use and state dependence
    • phase 4 depolarization in SA node (automaticity current) is dependent on Na+ channel opening
      • blockage results in ↓ slope of phase 4 depolarization and ↓ SA node rate
    • hyperkalemia causes ↑ toxicity for all class I drugs
Class IA
  • iaExamples
    • quinidine, procainamide, disopyramide
      • remember: quin + the amides
  • Effects
    • acts on atrial and ventricular arrhythmias
      • especially reentrant and ectopic supraventricular and ventricular tachycardia
    • ↓ rate of phase 0 depolarizating resulting in
      • ↑ QT interval
      • ↑ AP duration 
      • ↑ effective refractory period (ERP)
  • Toxicity
    • quinidine
      • cinchonism
        • headache, tinnitus, vertigo
      • thrombocytopenia
      • ↑ QT interval
        • can result in torsades de pointes
      • can enchance digoxin toxicity
    • procainamide
      • reversible SLE-like syndrome
        • remember: procAiNAmide (antinuclear antibody in SLE)
Class IB
  • ibExamples
    • lidocaine, mexiletine, tocainide
      • phenytoin can also fall into class IB
  • Effects
    • acts on ischemic or depolarized Purkinje and ventricular tissue
      • does not act on healthy or atrial tissue
      • effective in treating structurally abnormal tissue (especially post-MI)
      • useful in acute ventricular arrhythmias and in digitalis-induced arrhythmias
    • ↓ rate of phase 3 repolarization resulting in
      • ↓ AP duration
  • Toxicity
    • local anesthetic
    • CNS stimulation/depression
Class IC
  • icExamples
    • flecainide, encainide, propafenone
  • Effects
    • acts on His-Purkinje system in cardiac tissue WITHOUT structural abnormalities
      • useful in V-tachs progressing to VF and refractory SVT
      • drugs of last resort
    • no effect on AP duration
  • Toxicity
    • proarrhythmic
    • contraindicted with structural abnormalities
      • e.g., post-MI
    • significantly prolongs refractory period in AV node
Use Dependence
  • Higer rates of depolarization = increased Na+ channel blockade due to channels spending less time in the resting state
    • type 1C antiarrythmics
      • bind Na+ channels the strongest
      • have the highest likelihood of use dependence
    • type 1B antiarrythmics
      • bind the least avidly to Na+ channels
      • minimal cumulative effect over multiple cardiac cycles
      • more selective for ischemic myocardium
      • lowest likelihood of use dependence
  • Na+ channel binding strength:
    • 1C > 1A > 1B
Class II - β-blockers
  • Examples
    • propranolol, esmolol, metoprolol, atenolol, timolol
      • esmolol very short acting
  • Mechanism
    • ↓ slope of phase 4 resulting in ↓ automaticity
      • due to ↓ cAMP, ↓ Ca2+ currents
      • results in ↑ PR interval, ↓ conduction in AV node
  • Clinical use
    • ventricular tachycardia, SVT
    • slowing ventricular rate during atrial fibrillation and atrial flutter
    • post-MI arrhythmia prophylaxis (cardioprotective)
  • Toxicity
    • cardiovascular effects
      • bradycardia, AV block, CHF
    • CNS effects
      • sedation, sleep alterations, depression
    • may mask the signs of hypoglycemia
    • impotence
    • exacerbation of asthma
      • only for non-selective (non-beta1 specific)
    • metoprolol can cause dyslipidemia
    • treat overdose with glucagon 
      • ↑ cAMP via a mechanism independent of beta receptors
Class III - K+ Channel Blockers
  • iiiExamples 
    • sotalol, ibutilide, bretylium, dofetilide, amiodarone
  • Mechanism 
    • ↑ phase 3
      • due to ↓ K+ current
      • results in ↑ AP duration, ↑ ERP, ↑ QT interval
    • effective for antrial and ventricular arrhythmias
    • antiarrhythmics of last resort
    • amiodarone has class I, II, III, and IV effects
      • due to alterations lipid membrane
  • Toxicity
    • torsades de pointes due to ↑ QT interval
      • amiodarone is the only example of a drug that lengthens QT but does not have risk of torsades de pointes
    • sinus bradycardia
    • sotalol
      • excessive β blockade 
    • bretylium
      • new arrhythmias
      • ↓ BP
    • amiodarone
      • pulmonary fibrosis
      • hepatotoxicity
      • hypothyroidism/hyperthyroidism
        • amiodarone is 40% iodine by weight (amIODarone)
        • must watch LFTs, TFTs, PFTs
      • corneal deposits
      • photosensitivity
      • skin color changes (blue/gray)
      • neurologic effects
      • constipation
      • cardiovascular effects
        • bradycardia, heart block, CHF
Class IV - Ca2+ Channel Blockers
  • Examples
    • verapamil, diltiazem
      • note: other Ca2+ channel blockers (nifedipine, amlodipine) have little action on the heart
  • Mechanism
    • ↓ L-type Ca2+ channels current primarily in AV nodal cells
      • L-type Ca2+ channels responsible for the plateau phase
    • results in ↓ conduction velocity, ↑ ERP, ↑ PR interval
    • used in prevention of nodal arrhythmias, AV nodal reentry
  • Toxicity
    • antimuscarinic effects
      • constipation, diziness, flushing
    • edema
    • CV effects
      • negative ionotropy, AV block, sinus node depression 
Question
1 of 3
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options